Edward J Gane

19PUBLICATIONS
75CO-AUTHORS
Occupational epidemiologyPharmacogenomicsHaematological tumoursMedical devicesEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jun 10, 2026
Letter: Reconsidering Tenofovir Disoproxil Fumarate Use in Light of Emerging Safety Evidence-Authors' Reply.

|May 21, 2026
Safety, Tolerability, and Pharmacodynamics of GS-4224 in Healthy Participants and Participants With Chronic Hepatitis B.

|May 19, 2026
Effect of tiomolibdate choline on copper balance in patients with Wilson disease: An open-label phase 2 trial.

|Nov 21, 2025
A Phase 1 study of the safety, tolerability, and pharmacokinetics of ALG-000184 (pevifoscorvir sodium), a novel Class E capsid assembly modulator, in healthy participants.

Ed Gane, Christian Schwabe, Min Wu

|Aug 12, 2025
Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment.

Grace Lai-Hung Wong, Edward Gane, Calvin Q Pan

|Jan 13, 2025
Liver Transplantation in Well-Selected Class III Obese Recipients Yields Good Outcomes.

Kevin Yi, Vicki Avery, John McCall

Pageof 4

Frequent Collaborators

3 joint publications

Wan-Long Chuang

2 joint publications

Joris Vandenbossche

2 joint publications

Nele Goeyvaerts

2 joint publications

Kosh Agarwal